Answers are grounded in this paper and cite their sources.
Demonstrates enhanced molecular imaging and targeted therapy using nanotechnology, indicating improved treatment outcomes.
Biomedical nanotechnology is a cross-disciplinary area of research in science, engineering and medicine with broad applications for molecular imaging, molecular diagnosis, and targeted therapy. The basic rationale is that nanometer-sized particles such as semiconductor quantum dots and iron oxide nanocrystals have optical, magnetic or structural properties that are not available from either molecules or bulk solids. When linked with biotargeting ligands such as monoclonal antibodies, peptides or small molecules, these nanoparticles can be used to target diseased cells and organs (such as malignant tumors and cardiovascular plaques) with high affinity and specificity. In the "mesoscopic" size range of 5-100 nm diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic, or magnetic) and therapeutic (e.g., anticancer) agents.
No takes yet. Share an insight, caveat, or question.
Shuming Nie (2009) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: